Tenderwize
Retour à la recherche

Contrat de remise non exclusif pour la combinaison de principes actifs R03AL09

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline May 27, 2028 · 553 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Glycopyrroniumbromid, Formoterol und Beclometason (ATC-Code: R03AL09).

54/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

54 / 100

Complexité

64 / 100

Facteurs de risque

Participation is restricted to pharmaceutical entrepreneurs meeting the statutory AMG definition, and local representat...

Electronic submission is not allowed and receipt by AOK Niedersachsen is decisive. The exact delivery address and docum...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
May 27, 2028

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Conclusion of non-exclusive pharmaceutical rebate agreements under Section 130a(8) SGB V for the active-ingredient combination glycopyrronium bromide, formoterol and beclometasone, ATC code R03AL09.
  • Open-house participation is available to eligible pharmaceutical companies or communities of pharmaceutical companies on identical contractual terms.
Afficher le résumé complet

AOK Niedersachsen intends to conclude a non-exclusive pharmaceutical rebate agreement under Section 130a(8) SGB V for products containing glycopyrronium bromide, formoterol and beclometasone (ATC R03AL09). This is an open-house model: eligible pharmaceutical companies receive identical terms, there is no selection decision or individual negotiation, and contracts may be concluded during the term. The agreement may end automatically if exclusive contracts enter into force. The contract documents and value information were not provided for analysis.

Risques

Participation is restricted to pharmaceutical entrepreneurs meeting the statutory AMG definition, and local representat...

Electronic submission is not allowed and receipt by AOK Niedersachsen is decisive. The exact delivery address and docum...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The agreement is non-exclusive and follows an open-house model with no selection decision by AOK Niedersachsen.
  • The same contract contents, conditions and access procedure apply to all participants; individual negotiations are generally not conducted.
  • The maximum contract duration is 24 months. The earliest contract start is 1 August 2026 and all contracts end no later than 31 July 2028.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Non-exclusive rebate agreement for R03AL09 medicines

Non-exclusive rebate agreement for medicines containing glycopyrronium bromide, formoterol and beclometasone under the open-house model. Contracts may be concluded with eligible pharmaceutical companies during the maximum 24-month period, subject to identical conditions and possible replacement by exclusive contracts.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Jul 2026 - Jul 2028

Catégorie

Pharmaceutical products

Date limite

Deadline May 27, 2028

Détails de la procédure

Date de publication
09 Jun 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
398904-2026

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy